Inventor · disambiguated record
Marc A. Gavin
Also filed as: GAVIN MARC A · GAVIN MARC ALAIN
11 granted patents·7 pending applications·145 citations·filing 2010–2025
90Inventor score
Top patents by PatentIndex Score
18 records- 0197US9580486B2Interleukin-2 muteins for the expansion of T-regulatory cellsAMGEN INC·Filed 2014·Granted Feb 28, 2017·47 cites·27 claims
- 0296US9932380B2Interleukin-2 muteins for the expansion of T-regulatory cellsAMGEN INC·Filed 2017·Granted Apr 3, 2018·23 cites·23 claims
- 0396US9732134B2Method of treating graft versus host disease using IL-2 muteinsAMGEN INC·Filed 2012·Granted Aug 15, 2017·50 cites·3 claims
- 0494US10829535B2Interleukin-2 muteins for the expansion of T-regulatory cellsAMGEN INC·Filed 2018·Granted Nov 10, 2020·5 cites·5 claims
- 0592US10851144B2Interleukin-2 muteins for the expansion of T-regulatory cellsAMGEN INC·Filed 2016·Granted Dec 1, 2020·16 cites·10 claims
- 0688US2024327485A1Interleukin-2 muteins for the expansion of t-regulatory cellsAMGEN INC·Filed 2024·Application pending·0 cites
- 0783US12297248B2Methods of treating graft versus host disease using IL-2 muteinsAMGEN INC·Filed 2022·Granted May 13, 2025·0 cites·6 claims
- 0880US9309318B2Compositions relating to anti-IL-21 receptor antibodiesAMGEN INC·Filed 2013·Granted Apr 12, 2016·4 cites·6 claims
- 0977US2024327486A1Interleukin-2 muteins for the expansion of t-regulatory cellsAMGEN INC·Filed 2024·Application pending·0 cites
- 1076US11976102B2Interleukin-2 muteins for the expansion of T-regulatory cellsAMGEN INC·Filed 2020·Granted May 7, 2024·0 cites·17 claims
- 1176US2024307537A1Methods and Compositions for Treating CancerOMEROS CORP·Filed 2023·Application pending·0 cites
- 1273US2025270271A1Methods of treating graft versus host disease using il-2 muteinsAMGEN INC·Filed 2025·Application pending·0 cites
- 1367US11976103B2Interleukin-2 muteins for the expansion of T-regulatory cellsAMGEN INC·Filed 2020·Granted May 7, 2024·0 cites·15 claims
- 1465US11560415B2Method of promoting regulatory T-cell proliferationAMGEN INC·Filed 2017·Granted Jan 24, 2023·0 cites·5 claims
- 1562US2020345725A1Methods and Compositions for Treating CancerOMEROS CORP·Filed 2020·Application pending·0 cites
- 1657US2023285556A1Methods and compositions for treating cancerOMEROS CORP·Filed 2022·Application pending·0 cites
- 1752US2011274650A1Compositions and methods of treating inflammatory and autoimmune diseasesAMGEN INC·Filed 2010·Application pending·0 cites
- 1851US10184002B2Methods and compositions relating to anti-IL-21 receptor antibodiesAMGEN INC·Filed 2016·Granted Jan 22, 2019·0 cites·21 claims
Join the waitlist — get patent alerts
Get an alert when Marc A. Gavin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →